A case study in how pharmacogenomic testing can be helpful if not always essential
$14M NIH grant supports research toward medications to prevent progression
Retrospective study yields clues to understanding risk of secondary myeloid neoplasms
New Cleveland Clinic fellowship fosters expertise in the genetics of epilepsy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Integrates genetic and clinical data to distinguish from GEFS+ and milder epilepsies
First-of-kind study aims to enable prevention of brain disorders before symptoms appear
Advanced genomic research techniques show potential to treat a variety of conditions
Virtual clinic supports oncologists by educating patients and making treatment recommendations
Molecular tumor profiling is available to patients
Truly personalized radiotherapy may be within reach
Advertisement
Advertisement